Gastroenterology

Gastroenterology Seminar CME / CPD 

Full Course:  20 AMA PRA Category I Credits for CME / CEU / CPD

Short Course:  10 AMA PRA Category I Credits for CME / CEU / CPD

Course(s) are appropriate for:  Gastroenterologists, Internal Medicine Physicians, Subspecialist Physicians, General Practitioners, Nurses, Nurse Practitioners

Series 44 (GI44) Topics Include:  Prevent Development of Parastomal Hernias, Treatments for Portal Hypertension, Empiric Sphincterotomy for Management of SOD, Drug-Induced Liver Injury, Management of IBD, and more.

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Full Course:
GI44
Full Course Price:
$580
Short Course:
GI44A, GI44B
Short Course Price:
$485
Format:
Available in Audio format.

Course Topics

Sphincter of Oddi/Reflux/Foreign Bodies

Assess the value of manometry for predicting long-term outcomes of sphincterotomy in patients with biliary pain or SOD; Discuss the role of empiric sphincterotomy for management of SOD; Summarize adverse events associated with long-term use of PPI therapy; Use strategies to minimize long-term exposure to PPI therapy; Implement strategies for removal of foreign bodies from the gastrointestinal tract based on characteristics of patient and foreign body.

Challenges in Colon Surgery

Compare efficacy, mortality, and complications among surgical procedures for perforated diverticulitis; Summarize a proposed algorithm for pre- and perioperative management of perforated diverticulitis in patients with septic shock; Discuss the benefits and drawbacks of different techniques for surgical repair of parastomal hernias; Utilize strategies during creation of stomas to prevent the future development of parastomal hernias. Identify and manage anastomotic leaks based on their anatomic location and the condition of the patient.

IBD: Nutrition/Health

Identify dietary factors that increase the risk for inflammatory bowel disease; Counsel patients on strategies for diet and supplementation that address deficiencies in protein and micronutrients and that maintain nutritional status during disease flares; Discuss the role of enteral and total parenteral nutrition in the management of nutritional status; Perform clinical measurements and nutritional assessments to evaluate disease activity, nutritional status, and response to therapy; Evaluate patients for depression and anxiety, infectious diseases and immunization status, and risk for cancer.

Colon Cancer Update

Identify patients at high risk for anal dysplasia and cancer; Assess the efficacy of aggressive management for preventing recurrence of high-grade dysplasia or development of anal cancer; Use tumor testing, clinical and pathologic criteria, and prediction models to estimate probability of a germline mutation associated with colorectal cancer; Explain inheritance patterns, extracolonic manifestations, associated malignancies, and screening and management strategies for colorectal cancer syndromes; Weigh the pros and cons of screening tests for colorectal cancer.

Cirrhosis/Liver Injury

Characterize hospital readmission in patients with cirrhosis; Assess the effectiveness of interventions for reducing hospital readmissions of patients with cirrhosis; Identify drugs that commonly cause injury to the liver; Differentiate between immune-mediated and metabolic causes of drug-induced liver injury; List clinical and histologic characteristics of various types of drug-induced liver injury.

Surgical Trends in IBD

Assess the reasons for discrepancies in data reporting of postoperative complications; Describe the disadvantages associated with the common mechanisms of measuring quality of care; Determine the risks associated with the use of biologic agents in patients requiring surgery for inflammatory bowel disease; Follow recent guidelines for performing colonoscopy and chromoendoscopy in patients with inflammatory bowel disease; Identify patients who may benefit from extended chemoprophylaxis for venous thromboembolism.

IBD: Medications/Pregnancy

Recognize the indications for local therapy, systemic therapy, and combination therapy for the management of inflammatory bowel disease; Identify the predictors of severity in Crohn disease and ulcerative colitis; Recommend the appropriate drugs for inflammatory bowel disease in patients who have undergone organ transplantation and in patients with previous cancer; Counsel women with inflammatory bowel disease of reproductive age about fertility, pregnancy planning, and other reproductive issues; Identify and prescribe drugs that are safe for pregnant and breastfeeding women with inflammatory bowel disease.

Update on Liver Disease

Select appropriate treatments for portal hypertension based on severity, cardiac output, and comorbidities; Compare and contrast methods for the management of variceal bleeding in patients with cirrhosis; Assess possible causes and options for the management of sarcopenia in patients with cirrhosis; Identify patients with acute-on-chronic liver failure using clinician assessment or scoring systems; Apply scoring systems to determine eligibility for liver transplantation and probability of survival in patients with acute-on-chronic liver failure.

Inflammatory Bowel Disease: New Therapies/Cancer Prevention

Explain how novel mechanisms of action of new therapies for IBD may improve clinical outcomes and reduce risk for side effects; Summarize the effects of previous exposure to anti-tumor necrosis factor therapies on response to novel agents for IBD; Identify common side effects and adverse events associated with use of novel treatments for IBD; Counsel patients with IBD on risk factors for malignancy; Provide recommendations for surveillance of malignancies associated with IBD.

Liver Transplantation 2018

Review the principles of allocation used in organ, and particularly liver, transplantation; Explain the concept of liver transplant redistribution (or broader sharing) to improve fairness in geographic access to transplantation; Discuss the concerns involved with HCV-positive donors and HCV-positive recipients in liver transplantation; Describe the advantages and disadvantages of telehealth in transplant hepatology; Identify conditions and situations that lend themselves well to management via telehealth in hepatology

Challenges in Colon Surgery

Compare efficacy, mortality, and complications among surgical procedures for perforated diverticulitis; Summarize a proposed algorithm for pre- and perioperative management of perforated diverticulitis in patients with septic shock; Discuss the benefits and drawbacks of different techniques for surgical repair of parastomal hernias; Utilize strategies during creation of stomas to prevent the future development of parastomal hernias. Identify and manage anastomotic leaks based on their anatomic location and the condition of the patient.

Colon Cancer Update

Identify patients at high risk for anal dysplasia and cancer; Assess the efficacy of aggressive management for preventing recurrence of high-grade dysplasia or development of anal cancer; Use tumor testing, clinical and pathologic criteria, and prediction models to estimate probability of a germline mutation associated with colorectal cancer; Explain inheritance patterns, extracolonic manifestations, associated malignancies, and screening and management strategies for colorectal cancer syndromes; Weigh the pros and cons of screening tests for colorectal cancer.

Surgical Trends in IBD

Assess the reasons for discrepancies in data reporting of postoperative complications; Describe the disadvantages associated with the common mechanisms of measuring quality of care; Determine the risks associated with the use of biologic agents in patients requiring surgery for inflammatory bowel disease; Follow recent guidelines for performing colonoscopy and chromoendoscopy in patients with inflammatory bowel disease; Identify patients who may benefit from extended chemoprophylaxis for venous thromboembolism.

Update on Liver Disease

Select appropriate treatments for portal hypertension based on severity, cardiac output, and comorbidities; Compare and contrast methods for the management of variceal bleeding in patients with cirrhosis; Assess possible causes and options for the management of sarcopenia in patients with cirrhosis; Identify patients with acute-on-chronic liver failure using clinician assessment or scoring systems; Apply scoring systems to determine eligibility for liver transplantation and probability of survival in patients with acute-on-chronic liver failure.

Inflammatory Bowel Disease: New Therapies/Cancer Prevention

Explain how novel mechanisms of action of new therapies for IBD may improve clinical outcomes and reduce risk for side effects; Summarize the effects of previous exposure to anti-tumor necrosis factor therapies on response to novel agents for IBD; Identify common side effects and adverse events associated with use of novel treatments for IBD; Counsel patients with IBD on risk factors for malignancy; Provide recommendations for surveillance of malignancies associated with IBD.

Sphincter of Oddi/Reflux/Foreign Bodies

Assess the value of manometry for predicting long-term outcomes of sphincterotomy in patients with biliary pain or SOD; Discuss the role of empiric sphincterotomy for management of SOD; Summarize adverse events associated with long-term use of PPI therapy; Use strategies to minimize long-term exposure to PPI therapy; Implement strategies for removal of foreign bodies from the gastrointestinal tract based on characteristics of patient and foreign body.

IBD: Nutrition/Health

Identify dietary factors that increase the risk for inflammatory bowel disease; Counsel patients on strategies for diet and supplementation that address deficiencies in protein and micronutrients and that maintain nutritional status during disease flares; Discuss the role of enteral and total parenteral nutrition in the management of nutritional status; Perform clinical measurements and nutritional assessments to evaluate disease activity, nutritional status, and response to therapy; Evaluate patients for depression and anxiety, infectious diseases and immunization status, and risk for cancer.

Cirrhosis/Liver Injury

Characterize hospital readmission in patients with cirrhosis; Assess the effectiveness of interventions for reducing hospital readmissions of patients with cirrhosis; Identify drugs that commonly cause injury to the liver; Differentiate between immune-mediated and metabolic causes of drug-induced liver injury; List clinical and histologic characteristics of various types of drug-induced liver injury.

IBD: Medications/Pregnancy

Recognize the indications for local therapy, systemic therapy, and combination therapy for the management of inflammatory bowel disease; Identify the predictors of severity in Crohn disease and ulcerative colitis; Recommend the appropriate drugs for inflammatory bowel disease in patients who have undergone organ transplantation and in patients with previous cancer; Counsel women with inflammatory bowel disease of reproductive age about fertility, pregnancy planning, and other reproductive issues; Identify and prescribe drugs that are safe for pregnant and breastfeeding women with inflammatory bowel disease.

Liver Transplantation 2018

Review the principles of allocation used in organ, and particularly liver, transplantation; Explain the concept of liver transplant redistribution (or broader sharing) to improve fairness in geographic access to transplantation; Discuss the concerns involved with HCV-positive donors and HCV-positive recipients in liver transplantation; Describe the advantages and disadvantages of telehealth in transplant hepatology; Identify conditions and situations that lend themselves well to management via telehealth in hepatology

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include:  Internal MedicineObesityEndocrinology and Metabolic DisordersDiabetes

If you have taken the current Gastroenterology CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon.  There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.

For over 30 years, ASI has provided Continuing Medical Education, CME & CEU and Continuing Professional Development Education (CPD) for physicians and allied professionals in Gastroenterology plus over 40 other specialties and subspecialties.  Lectures are recorded annually at the top seminars and conferences to provide the most current medical education to our clients.